Long‐term haematological response and maintained immunological function after laparoscopic subtotal splenectomy in patients with hereditary spherocytosis

Author:

Münch Alica L.1,Jacobsen Eva‐Maria1,Schulz Ansgar1,Loichinger Wolfgang1,Wowra Tobias1,Schiefele Lisa1,Elsner Julia1,Westhoff Mike‐Andrew1,Serra Alexandre2,Strauss Gabriele3,Schaarschmidt Klaus4,Cario Holger1ORCID

Affiliation:

1. Department of Paediatrics University Medical Center Ulm (UUMC) Ulm Germany

2. Department of Paediatric Surgery UUMC Ulm Germany

3. Department of Paediatrics Helios Clinic Berlin‐Buch Germany

4. Department of Paediatric Surgery Helios Clinic Berlin‐Buch Germany

Abstract

AbstractIntroductionSubtotal or total splenectomy are recommended in severe and should be considered in intermediate forms of hereditary spherocytosis (HS). Data on laparoscopic subtotal splenectomy (LSTS) in HS patients are sparse.MethodsThirty three patients with HS (median age 10.7 years (yrs), range 1.8–15.5) underwent LSTS. Baseline and follow‐up investigation included haematological parameters, microscopic analysis of pitted erythrocytes (pitE), and B‐cell subpopulations assessed by flow cytometry. Results were compared to those of non‐splenectomised HS patients, HS patients after total splenectomy (TS), and healthy individuals.ResultsAfter LSTS, haemoglobin levels were normalised in all patients. During median long‐term follow‐up of 3.9 yrs (range 1.1–14.9), only four patients presented mild anaemia. Despite re‐growing of the remnant spleen none of the patients required a second surgical intervention. As compared to TS, PitE in LSTS patients were significantly lower and indicated normal to only moderately decreased spleen function. Relative but not absolute IgM memory B‐cell counts were reduced in both LSTS and TS patients.ConclusionsLSTS is effective for the treatment of patients with HS. A small remnant spleen is sufficient to provide adequate phagocytic function and to induce a pool of IgM memory B‐cells.

Publisher

Wiley

Subject

Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3